The HER-2/neu gene or c-erb B-2, localized on chromosome 17q, belongs to a family of tyrosine kinase receptors and shares extensive homology with the epidermal growth factor receptor. c-erb B-2 gene amplification and protein overexpression have been reported in several human cancers. The prognostic value of this genetic alteration in gastric carcinoma is far from being established. In the present study, formalin-fixed, paraffin-embedded gastric carcinoma tissues from 157 patients were evaluated for c-erb B-2 overexpression, by immunohistochemistry using a polyclonal antibody. c-erb B-2 expression was evaluated according to clinical and pathological parameters, and to the survival of the patients. Our results show that: (1) c-erb B-2 was overexpressed in 15.3% of gastric carcinoma cases; (2) c-erb B-2 overexpression was significantly more frequent in cardia (23.8%) and fundus/body (25.0%) carcinomas than in antrum (7.2%) carcinomas; (3) c-erb B-2 overexpression was significantly associated with venous invasion; (4) c-erb B-2 is a prognostic factor for gastric carcinoma.
1. Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer. Br J Surg84:1651-1664, 1997
2.
2. Marubini E, Bonfanti G, Bozzetti F, Borracchi P, Amadori D, Folli S, Nanni O, Gennari L. A prognostic score for patients resected for gastric cancer. Eur J Cancer29A:845-850, 1993
3.
3. Roder JD, Bottcher K, Siewert JR, Busch R, Hernmanek P, Meyer HJ. Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer72:2089-2097, 1993
4.
4. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study. Ann Surg228:449-461, 1999
5.
5. Maehara Y, Tomada M, Hasuda S, Kabashima A, Tokunaga E, Kakeji Y, Sugimachi K. Prognostic value of p53 protein expression for patients with gastric cancer-a univariate analysis. Br J Cancer79:1255-1261, 1999
6.
6. Roviello F, Marrelli D, Vindigni C, De Stefano A, Spine D, Pinto E. p53 accumulation is a prognostic factor in intestinal-type gastric carcinoma but not in the diffuse type. Ann Surg Oncol6:739-745, 1999
7.
7. Saito H, Tsujitani S, Katano K, Ikeguchi M, Maeta M, Kaibara N. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma. Cancer83:1094-1101, 1998
8.
8. Tahara E. Miolecular biology of gastric cancer. World J Surg19:484-488, 1995
9.
9. Kyokane K, Ito H, Sato Y, Ina K, Kusugani K. Expression of Bcl-2 and p53 correlates with morphology of gastric neoplasia. J Pathol184:382-389, 1998
10.
10. Kim JH,Uhm HD, Gong SJ, Shin DH, Choi JH, Lee HR, Nosh SH, Kim BS, Cho JY, Yoo NC, Chung HC, Roh JK, Min JS, Lee Ks, Kim BS. Relationship between p53 overexpression and gastric cancer progression. Oncology54:166-170, 1997
11.
11. Yoo CH, Noh SH, Kim H, Lee HY, Min JS. Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma. J Surg Oncol71:22-28, 1999
12.
12. Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T, Nakano H. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer85:1894-1902, 1999
13.
13. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A, Ullrich A. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science230:1132-1139, 1985
14.
14. Popescu NC, King CR, Kraus MH. Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32. Genomics4:362-366, 1989
15.
15. Schechter AL, Hung MC, Vaidyanathan L, Weinberg RA, Yang-Feng TL, Francke U, Ullrich A, Coussen L. The neu gene: An erb-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science229:976-978, 1985
16.
16. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamaoto T. The product of the human c-erb B-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity. Science232:1644-1646, 1986
17.
17. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD. Identification of heregulin, a specific activator of p185erbB2. Science256:1205-1210, 1992
18.
18. King CR, Krauss MH, Aaronson SA. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science229:974-976, 1985
19.
19. Yokota J, Toyosima K, Sugimura T, Yamamoto T, Terada M, Battifora H, Cline MJ. Amplification of cerbB-2 oncogene in human adenocarcinomas in vivo. Lancet1:765-767, 1986
20.
20. Cohen JA, Weiner DB, More KF, Kokai Y, Williams WV, Maguire HC, LiVolsi VA, Greene MI. Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (pl85neu) in normal and transformed epithelial tissues of the digestive tract. Oncogene4:81-88, 1989
21.
21. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science244:707-712, 1989
22.
22. Slamon DJ, Clark GM, Wong SG, Levin WY, Ullrich A, McGuire WL. Human breast cancer: Correlation of relapse and survival with amplification of the HER2/neu oncogene. Science235:177-182, 1987
23.
23. Park JB, Rhim JS, Park SC, Kimm SW, Kraus MH. Amplification, overexpression, and rearrangement of the erb B-2 protooncogene in primary human stomach carcinomas. Cancer Res49:6605-6609, 1989
24.
24. David L, Seruca R, Nesland JM, Soares P, Sansonetty F, Holm R, Børresen AL, Sobrinho-Simões M. c-erb B-2 expression in primary gastric carcinomas and their metastases. Modern Pathol5:384-390, 1992
25.
25. Heintz NH, Leslie KO, Rogers LA, Howard OL. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma. Arch Pathol Lab Med114:160-163, 1990
26.
26. Tervahauta A, Eskelinen M, Syrjanen S, Lipponen P, Pajarinen P, Syrjanen K. Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance. Anticancer Res11:1677-1681, 1991
27.
27. Mokbel K, Hassanally D. From HER-2 to herceptin. Curr Med Res Opin17:51-59, 2001
28.
28. Duffy MJ, Biochemical markers in breast cancer: Which ones are clinically useful?Clin Biochem34:347-352, 2001
29.
29. Bell R. Ongoing trials with trastuzumab in breast cancer. Ann Oncol12:S69-S73, 2001
30.
30. Piccart MJ. Proposed treatment guidelines for HER-2- positive metastatic breast cancer in Europe. Ann Oncol12:S89-S94, 2001
31.
31. Tsugawa K, Yonemura Y, Hirono Y, Fushida S, Kaji M, Miwa K, Miyazaki I, Yamamoto H. Amplification of the c-met, c-erb B-2 and epidermal growth factor gene in human gastric cancers: Correlation to clinical features. Oncology55:475-481, 1998
32.
32. Gurel S, Dolar E, Yerci O, Samli B, Ozturk H, Nak SG, Gulten M, Memik F. The relationship between c-erb B-2 expression and clinicopathological factors in gastric cancer. J Int Med Res27:74-78, 1999
33.
33. Orita H, Maehara Y, Emi Y, Kakeji V, Baba H, Korenaga D, Sugimachi K. c-erb B-2 expression is predictive for lymphatic spread of clinical gastric carcinoma. Hepatogastroenterology44:294-298, 1997
34.
34. Yonemura Y, Ninomiya I, Tsugawa K, Fushida S, Fujimura T, Miyazaki I, Uchibayashi T, Endou Y, Sasaki T. Prognostic significance of c-erb B-2 gene expression in the poorly differentiated type of adenocarcinoma of the stomach. Cancer Detect Prev22:139-146, 1998
35.
35. Dursum A, Poyraz A, Celik B, Akyol G. Expression of c-erb B-2 oncoprotein in gastric carcinoma: Correlation with histopathological characteristics and analysis of Ki-67. Pathol Oncol Res5:104-106, 1999
36.
36. Polkowski W, van Sandick JW, Offerhaus GJ, ten Kate FJ, Mulder J, Obertop H, van Lanschot JJ. Prognostic value of Lauren classification and c-erb B-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol6:290-297, 1999
37.
37. Albino AP, Jacne J, Altorki N, Blundell M, Urmacher C, Lauwers G, Nieddzwiecki D, Kelsen DP. Amplification of HER-2/neu gene in human gastric carcinomas: Correlation with primary site. Eur J Surg Oncol21:56-60, 1995
38.
38. Amadori D, Maltoni M, Volpi A, Nanni O, Scarpi E, Renault B, Pellegata NS, Gaudio M, Magni E, Ranzani GN. Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma. Cancer79:226-223, 1997
39.
39. Ortolani CM, Sundblad AS. Gastric cancer. Clinicopathological characteristics and expression of c-erb B-2 oncogene in 122 cases. Medicina (B Aires)53:97-102, 1993
40.
40. Siewert JR, Bottcher K, Stein HJ, Roder JD, Busch R. Problem of proximal third gastric carcinoma. World J Surg19:523-531, 1995
41.
41. Pinto-de-Sousa J, David L, Seixas M, Pimenta A. Clinico-pathological profiles and prognosis of gastric carcinoma from the cardia, fundus/body, and antrum. Dig Surg18:102-110, 2001
42.
42. Lauren P. The two histological main types of gastric carcinoma: Diffuse and the so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand64:31-49, 1965
43.
43. Carneiro F, Seixas M, Sobrinho-Simiões M. New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract191:571-584, 1995
44.
44. Ming SC. Gastric carcinoma: A pathobiological classification. Cancer39:2475-2485, 1977
45.
45. Sobin LH, Wittekind Ch, (eds.) TNM classification of malignant tumors, International Union Against Cancer, 5th ed.John Wiley & Sons, New York, 1997
46.
46. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc53:457-481, 1958
47.
47. Yonemura Y, Ninomiya I, Ohoyama S, Kimura H, Yamaguchi A, Fushida S, Kosaka T, Miwa K, Miyazaki I, Endou Y, Tanaka M, Sasaki T. Expression of c-erb B-2 oncoprotein in gastric carcinoma. Cancer67:2914-2918, 1991
48.
48. Yokota J, Yamamoto T, Miyajima N, Toyoshima K, Nomura N, Sakamoto H, Yoshida T, Terada M, Sugimura T. Genetic alterations of the c-erb B-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene2:283-287, 1988
49.
49. Mizutani T, Onda M, Tokunaga A, Yamanaka N, Sugisaki Y. Relationship of c-erb B-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer. Cancer72:2083-2088, 1993
